As­traZeneca rolls up car­dio­vas­cu­lar, re­nal and meta­bol­ic in­ter­con­nec­tions in film and dig­i­tal ef­fort

As­traZeneca is putting its car­dio­vas­cu­lar, re­nal and meta­bol­ic (CVRM) port­fo­lio in the spot­light with a short film and dig­i­tal cam­paign. The two-minute video lays out As­traZeneca’s am­bi­tions across the “com­plex and in­ter­con­nect­ed” dis­eases.

“By 2032, we aim to be lead­ing the world in CVRM ther­a­pies, with as many as 15 life-chang­ing new med­i­cines de­vel­oped and de­liv­ered by mak­ing the con­nec­tions that em­pow­er us to ful­fill our am­bi­tion and stop, and one day, cure these dis­eases,” the nar­ra­tor says.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER